CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![data analysis safety, software overlay, cyber security coding-GettyImages-1552877787]( "Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us")
Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells UsControlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.
-
![Artificial Intelligence, AI-GettyImages-2178269161]( "AI In Precision Medicine: From Predictive Insight To Operational Confidence In Complex Clinical Trials")
AI In Precision Medicine: From Predictive Insight To Operational Confidence In Complex Clinical TrialsAI-enabled precision medicine trials depend on strong data governance and security, enabling predictive operational intelligence while preserving human oversight and appropriate conventional analytics.
-
![GettyImages-944060504 coworkers computer]( "7 Silent Quality-Killers Of Clinical Trial Success")
7 Silent Quality-Killers Of Clinical Trial SuccessInvestigate seven hidden risks that quietly erode trial quality over time. Learn the early warning signs and how to catch and fix them before they escalate.
-
![Digital brain, AI, Machine Learning, AI Neural Network-GettyImages-2238702869]( "AI, Open Source, & the Future of Biostatistics")
AI, Open Source, & the Future of BiostatisticsAI and open-source tools are changing statistical programming. Learn how to validate, govern, and apply them without sacrificing the accuracy and oversight clinical research demands.
-
![Digital Twins Technology-GettyImages-1494714249]( "Digital Twins: From Protocol Design to Predictive Study Execution")
Digital Twins: From Protocol Design to Predictive Study ExecutionA growing generation of AI-enabled digital twin approaches offers a new path. Instead of treating the protocol as a static document, organizations can model it as a dynamic system.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Stabilizing A Biotech Sponsor's Data Management And Biostatistics Functions8/29/2026
Discover how a rapid mid-study data transition rescued an endangered clinical trial, cleaned up compromised data, and secured a critical interim database lock within twelve months.
-
Driving ROI: A Real-Time Clinical Trial Oversight Solution8/3/2026
Sample errors, delays, and query overload drain clinical trial budgets. Learn how real-time data capture can shorten timelines and protect data quality.
-
Accelerating A Schizophrenia Trial While Ensuring Quality7/31/2026
Tight timelines and rising patient targets don't have to derail a trial. See how speed and data quality can work together from enrollment to database lock.
-
Reserving Data Integrity With Retrospective Manual Entry7/5/2026
A look at implementing randomization mid-trial by reconstructing subject and inventory records without disrupting sites or compromising data integrity.
-
A Mission To Expand Recruitment Territory6/11/2026
Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.
CENTRAL LABORATORIES PRODUCTS & SERVICES
Enable secure, flexible data exchange with open REST integrations—streamlining workflows, reducing manual effort, and supporting modern, audit‑ready clinical operations.
Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.
Trial@home, CHDR’s dedicated strategy for off-site clinical trials, enables investigators to collect information as trial participants go about their day to day activities.
Elevate Your Clinical Research Data Collection
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
Our industry-leading clinical analytics experts build tools and solutions that efficiently facilitate data management and biometrics activities. By providing advanced services and automating technology, we're able to maximize efficiency, ease interpretation, and deliver actionable insights.
Neither traditional nor hybrid clinical trials can operate on rigid EDC systems.
They require flexible data collection systems that support protocol amendments without downtime and accept mobile data without hassle. As a cloud-native solution, TrialKit bends to accommodate mid-study changes. And as the first full-featured EDC platform available as a native mobile app, TrialKit flexes to meet the demands of traditional, hybrid/decentralized, and completely remote clinical trials.
Give your team the freedom to build, deploy, and manage their studies, their way—weeks faster than with rigid EDCs and for a fraction of the cost of the major players.
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
CENTRAL LABORATORIES SOLUTIONS
- De-Risk Randomization With The Endpoint Biostatistical Approach
- Medidata Clinical Data Studio: AI-Assisted Data Reconciliation
- Trial Results Summaries
- How The Sitetrove Diversity Module Can Diversify Studies
- Real World Data Solutions
- End-To-End Safety Solutions Designed For Success
- RWD Solutions
- Medidata Professional Services Streamlines TSDV Adoption
- Accelerate Approval Of Novel Therapies
- Modernize Clinical Research With Continuous Digital Data
VIDEOS
- Governing The Decisions: Where AI Is Hardest, And Where We Already Live
- Live AI Demonstration: 15 Minutes. From Nothing To Validation-Ready
- Clinical Innovations In AI
- Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale
- How Our Organizations Advancements Are Shaping The Future Of RTSM
NEWS
- Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation In Clinical Study
- Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
- Ypsomed Opens Production Site In China
- Ypsomed Launches YpsoLoop As The First Autoinjector Platform Designed For Circularity
- Ypsomed Expands Offering For Clinical Studies
- Ypsomed Receives The Red Dot Design Award 2026 For YpsoLoop
- Ypsomed Receives FDA Clearance For SmartPilot
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- Avance Clinical Announces Asia Pacific And Mainland China Expansion Ahead Of BIO International Convention 2026
- The Ottawa Hospital's Biotherapeutics Manufacturing Centre (BMC) Makes Breakthroughs Break Through As Boreal Biomanufacturing
- Suvoda Patient App Earns "Best Patient Relationship Management Solution" In 2026 MedTech Breakthrough Awards Program
- Quotient Sciences Advances AI-Designed Drug Product Into Clinical Development
- Paradigm Health Announces Collaboration With The FDA To Transform Regulatory Review Of Clinical Trial Data
- Inside Information: Nanoform Signs First Exclusivity Agreement For Ultra-High Concentration Subcutaneous Delivery
- Suvoda Announces Agentic RTSM, Enabling The Reduction Of Clinical Trial Startup Timelines By Up To 80%
- Signant Health Enters Definitive Agreement To Acquire Ametris
- Crucial Data Solutions Expands TrialKit AI With Study Simulation And Validation Capabilities
- AI HealthTech Pioneer Biorce Opens U.S. Offices In Austin To Accelerate Global Expansion
- Signant Health Appoints Specialist Physician And Clinical Research Expert Dr. Graham C. Ellis As Clinical Vice President To Strengthen Metabolic Disease And Diabetes Trial Capabilities
- Suvoda Advances Clinical Trial Financial Planning With Support For Complex Multi-Payee Budgets
- Suvoda Named "Most Innovative Clinical Trial Technology Firm Of 2026"
- Avance Clinical Appoints Liahna Toy To Lead Global Early Phase Center Of Excellence
- Avance Clinical Strengthens Global Oncology Offering With Acquisition Of U.S-Based LumaBridge
- Health Equity Research Goes Global—Without Waiting For Perfect Data
- International Study Confirms Universal Digital Health Framework
- ISPOR Announces New Executive Director
- Quotient Sciences Extends Commercial Manufacturing Partnership For Ultra-Rare Disease Treatment
- Sygnature Discovery Unveils Strategic Rebrand To Cement Status As A Global Drug Discovery Partner
- Suvoda Sets New Standard For Streamlined Patient And Site Experience In Clinical Trials
- Suvoda IRT Named A Leader In Everest Group's RTSM PEAK Matrix®